Management of Hypercalcemia

Assessment and Diagnosis

• A corrected calcium level of 2.72 mmol/L exceeds the recommended upper limit of 2.54 mmol/L for patients, indicating significant hypercalcemia, according to the American Journal of Kidney Diseases 1, 2
• The formula for correcting total calcium for albumin is: Corrected total calcium (mg/dL) = Total calcium (mg/dL) + 0.8 [4 - Serum albumin (g/dL)] [3]

Management Algorithm for Hypercalcemia

Step 1: Adjust Calcium-Based Medications

• If the patient is taking calcium-based phosphate binders, reduce the dose or switch to a non-calcium-containing phosphate binder, as recommended by the American Journal of Kidney Diseases 2, 4
• If the patient is taking vitamin D supplements or active vitamin D sterols, reduce the dose or discontinue therapy until calcium levels return to the target range of 2.10-2.37 mmol/L (8.4-9.5 mg/dL) 2, 4

Step 2: Dietary Modifications

• Restrict dietary calcium intake to help lower total calcium levels, according to the American Journal of Kidney Diseases 5
• Ensure total elemental calcium intake (dietary plus supplements) does not exceed 2,000 mg/day 5

Step 3: Consider Dialysis if Applicable

• For patients with kidney failure (CKD Stage 5) with persistent hypercalcemia despite medication adjustments, consider dialysis using low dialysate calcium (1.5-2.0 mEq/L) for 3-4 weeks, as recommended by the American Journal of Kidney Diseases 2, 4

Step 4: Monitor and Follow-up

• Recheck serum calcium, phosphorus, and PTH levels within 1-2 weeks after intervention, according to the American Journal of Kidney Diseases 2

Special Considerations

• If the patient has CKD, maintain calcium-phosphorus product at <55 mg²/dL² to prevent soft tissue calcification, as recommended by the American Journal of Kidney Diseases 2, 5
• For patients with severe vascular or soft-tissue calcifications, non-calcium-containing phosphate binders are preferred, according to the American Journal of Kidney Diseases 5